Engineered IgM antibodies

Sanofi and IGM Biosciences and partner over new class of antibody medicines for the treatment of cancer, immunology, and inflammatory diseases

(PRESS RELEASE) SANOFI, 29-Mar-2022 — /EuropaWire/ — Sanofi (EPA: SAN), a global biopharmaceutical company focused on human health, has announced…

2 years ago